FDA in Favor of Off-Label Marketing - PDF by GlobalData

VIEWS: 13 PAGES: 10

More Info
									FDA in Favor of Off-Label Marketing
                                                                              Reference Code: GDME0643VPT

                                                                              Publication Date: NOV 2008




Medical Equipment Viewpoint                                                            GDME0643VPT / Published NOV 2008
© GlobalData. This brief is a licensed product and is not to be photocopied                                      Page 1
-
Table of Contents



1           Table of Contents

1      Table of Contents ........................................................................................................2

1.1       List of Figures..................................................................................................................................................... 3


2      GlobalData Viewpoint ..................................................................................................4

2.1       Summary .............................................................................................................................................................. 4


3      FDA in Favor of Off-Label Marketing..........................................................................5

3.1    Current Scenario................................................................................................................................................ 5
  3.1.1    Pros of Off-Label Prescribing ..................................................................................................................... 5
  3.1.2    Cons of Off-Label Prescribing .................................................................................................................... 6

3.2    FDA’s Perspective ............................................................................................................................................. 6
  3.2.1   Strong supporter of drug sales................................................................................................................... 6
  3.2.2   Limited but Effective Checks on the Manufacturers .......
								
To top